TSPYL5 and non-small cell lung carcinoma: On the glucocorticoid axis, GR activation suppresses ERK signaling and induces G1 arrest/senescence in NSCLC models [55], but the GR also cooperates with activated STAT3 to transactivate TSPYL5, fostering growth and chemoresistance [78].